Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-receptor

Journal of Neuroscience

Volumn 18, Issue 18, 1998, Pages 7285-7295

  Matthes, H W D ^a   Smadja, C ^b   Valverde, O ^b   Vonesch, J L ^c   Foutz, A S ^d   Boudinot, E ^d   Denavit Saubie M ^d   Severini, C ^e   Negri, L ^e   Roques, B P ^b   Maldonado, R ^b   Kieffer, B L ^a,d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d CNRS   (France)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

G protein coupling; Respiration; Vas deferens; analgesia; Opioid receptor knock out; opioid receptor interactions

Indexed keywords

DELTA OPIATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RESPIRATION CONTROL; RESPIRATION DEPRESSION; TAIL FLICK TEST; VAS DEFERENS;

EID: 17344370360     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-18-07285.1998     Document Type: Article

References (22)

1. 1 receptor stimulation. Eur J Pharmacol 216:157-166.
2. Bartlett Jr D, Tenney SM (1970) Control of breathing in experimental anemia. Respir Physiol 10:384-395.
3. Brown BL, Albano JDM, Ekins RP, Sgherzi AM, Tampion W (1971) A sample and sensitive saturation assay method for measurement of adenosine 3′-,5′-cyclic monophosphate. Biochem J 121:561-562.
4. Corbett AD, Paterson SJ, Kosterlitz HW (1993) Selectivity of ligands for opioid receptors. In: Handbook of experimental pharmacology, Vol 104, Opioids I (Herz A, cd), pp 645-679. New York: Springer.
5. Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F (1988) Direct dependence studies in rats with agents selective for different types of opioid receptors. J Pharmacol Exp Ther 246:950-955.
6. Cvejic S, Devi LA (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
7. Denavit-Saubié M, Foutz AS (1997) Neuropharmacology of respiration. In: Neural control of respiratory muscles (Miller D, Bianchi AL, Bishop BP, eds), pp 143-157. Boca Raton, FL: CRC.
8. Di Chiara G, North A (1992) Neurobiology of opiate abuse. Trends Pharmacol Sci 13:185-193.
9. Dickenson AH (1991) Mechanisms of the analgesic action of opiates and opioids. Br Med Bull 47:690-702.
10. France CP, Medzihradsky F, Woods JH (1994) Comparison of kappa opioids in Rhesus monkeys: behavioural effects and receptor binding affinities. J Pharmacol Exp Ther 268:47-58.
11. Gacel GA, Fellion E, Baamonde A, Daugé V, Roques BP (1990) Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of δ-opioid receptors. Peptides 11:983-988.
12. Gavériaux-Ruff C, Matthes HW, Peluso J, Kieffer BL (1998) Absence of morphine immunosuppression in mice lacking the mu-opioid receptor gene. Proc Natl Acad Sci USA 95:6326-6330.
13. Goldstein A, Naidu A (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 36:265-272.
14. Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebroventricular injections of drugs in conscious mice. Br J Pharmacol 12:12-16.
15. Hughes J, Kosterlitz HW, Leslie FM (1975) Effects of morphine on adrenergie transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br J Pharmacol 53:371-377.
16. Ji R-R, Zhang Q, Law P-Y, Low HH, Elde R, Hökfelt T (1995) Expression of ; μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15:8156-8166.
17. Jiang Q, Mosberg HI, Porreca F (1990) Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J Pharmacol Exp Ther 254:683-689.
18. Kalso EA, Sullivan AF, McQuay HJ Dickenson AH (1992) Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective δ-opioid receptor agonist. Eur J Pharmacol 216:97-101.
19. Kitchen I, Slowe SJ, Matthes HWD, Kieffer BL (1997) Quantitative autoradiographic mapping of mu, delta and kappa opioid receptors in knock-out mice lacking the mu-opioid receptor gene. Br Res 778:73-78.
20. Lahti RA, von Voigtlander PF, Barsuhn C (1982) Properties of a selective kappa agonist, U-50, 488H. Life Sci 31:2257-2260.
21. Maldonado R, Negus S, Koob GF (1992) Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 31:1231-1241.
22. Mansour A, Watson SJ (1993) Anatomical distribution of opioid receptors in mammalians: an overview. In: Handbook of experimental pharmacology, Vol 104, Opioids I (Herz A, ed), pp 79-105. New York: Springer.